{"id":4051,"date":"2021-07-19T23:52:51","date_gmt":"2021-07-19T23:52:51","guid":{"rendered":"https:\/\/curesz.org\/?page_id=4051"},"modified":"2023-11-15T14:21:44","modified_gmt":"2023-11-15T19:21:44","slug":"tardive-dyskinesia-dawn-of-hope","status":"publish","type":"page","link":"https:\/\/curesz.org\/zh\/tardive-dyskinesia-dawn-of-hope\/","title":{"rendered":"\u8fdf\u53d1\u6027\u8fd0\u52a8\u969c\u788d\uff1a\u5e0c\u671b\u7684\u66d9\u5149"},"content":{"rendered":"

<\/span><\/div>

Dr. Craig Chepke<\/a>, Member, Board of Directors, The CURESZ Foundation, Private Practice Psychiatrist and Adjunct Assistant Professor of Psychiatry, University of North Carolina School of Medicine<\/p>\n<\/div><\/div><\/div>

My\u00a0last column<\/a>\u00a0discussed that the removal of the medication that causes Tardive Dyskinesia (TD) rarely results in remission, and therefore requires its own speci\ufb01c treatment. However, there were no FDA approved treatments prior to 2017. The few options for which the American Academy of Neurology (AAN) made even a moderate recommendation had signi\ufb01cant problems: clonazepam has a serious risk of physical dependency, and certain over- the- counter supplements like ginkgo biloba have been found by the U.S. Government Accountability Of\ufb01ce to contain much less than the amount advertised, or even none.1<\/sup><\/p>\n

Worse yet, the medication that seems to have become the de facto standard-of-care in the United States for nearly all drug-induced movement disorders is benztropine (\u201cCogentin\u201d). Not only does it carry a heavy side-effect burden, its use in TD has been categorized as \u201cunsubstantiated\u201d by the AAN because there have been no controlled clinical trials. Even the manufacturer\u2019s of\ufb01cial prescribing information says benztropine does not help TD and can aggravate its symptoms.2<\/sup><\/p>\n

Tetrabenazine, a medication from the 1950s, was not originally intended to treat TD but was found to have some bene\ufb01t in other hyperkinetic movement disorders. Tetrabenazine inhibits a protein called VMAT2, which collects dopamine for release. People with TD have hypersensitive motor circuits, so inhibiting VMAT2 reduces the amount of dopamine released into those areas, alleviating some of the symptoms. Unfortunately, the active components of tetrabenazine are eliminated from the body so quickly, it must be taken three times a day and leads to greater side effects, which limited its use.<\/p>\n

In 2017, the FDA brought new hope to those suffering with TD by approving two highly effective medications to treat it. Both valbenazine and deutetrabenazine were derived from the tetrabenazine prototype but delivered improvements in side effects and convenience by slowing its metabolism \u2013 each with a different twist. Valbenazine slows elimination by elegantly attaching the amino acid valine to the component of tetrabenazine that is the most potent and selective. Deutetrabenazine slows the elimination by cleverly swapping eight of tetrabenazine\u2019s hydrogen atoms for those of a close variant of hydrogen called deuterium.<\/p>\n

Valbenazine and deutetrabenazine are both usually well-tolerated and have roughly similar bene\ufb01ts on average. Depending on the person, one may be more favorable than the other, and each has a different trade-off. Valbenazine has two once a day dosing options, both of which can be therapeutic. Deutetrabenazine has more potential dose options, but must be taken twice a day and requires titration over several weeks to the effective doses. VMAT2 inhibitors only treat the symptoms of TD and are not curative. If treatment with any of them is stopped, the symptoms return to their pre-treatment levels. Still, an increasing focus of psychiatric research involves circuits in the brain that use the neurotransmitter glutamate, which facilitates \u201csynaptic plasticity,\u201d essentially the brain\u2019s ability to rewire itself. It will take much more investigation, but it is theoretically possible that future medications that modulate glutamate signaling could be found to help the brain remodel itself from the damage of TD.<\/p>\n

Perhaps the dawn of hope for TD has only begun!<\/b><\/p>\n

References:<\/p>\n

1.\u00a0https:\/\/www.gao.gov\/assets\/700\/696047.pdf<\/a>
\n2. Benztropine mesylate [package insert], Lake Forest, IL: Akorn, Inc. 2016.<\/p>\n

<\/h2>\n<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>\n<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4051","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nTardive Dyskinesia: Dawn of Hope - CURESZ Foundation<\/title>\n<meta name=\"description\" content=\"In 2017, the FDA brought new hope to those suffering with TD by approving two highly effective medications to treat it.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/curesz.org\/zh\/tardive-dyskinesia-dawn-of-hope\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tardive Dyskinesia: Dawn of Hope - CURESZ Foundation\" \/>\n<meta property=\"og:description\" content=\"In 2017, the FDA brought new hope to those suffering with TD by approving two highly effective medications to treat it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/curesz.org\/zh\/tardive-dyskinesia-dawn-of-hope\/\" \/>\n<meta property=\"og:site_name\" content=\"CURESZ Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cureszorg\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-15T19:21:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cureszorg\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/curesz.org\\\/tardive-dyskinesia-dawn-of-hope\\\/\",\"url\":\"https:\\\/\\\/curesz.org\\\/tardive-dyskinesia-dawn-of-hope\\\/\",\"name\":\"Tardive Dyskinesia: Dawn of Hope - CURESZ Foundation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/curesz.org\\\/#website\"},\"datePublished\":\"2021-07-19T23:52:51+00:00\",\"dateModified\":\"2023-11-15T19:21:44+00:00\",\"description\":\"In 2017, the FDA brought new hope to those suffering with TD by approving two highly effective medications to treat it.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/curesz.org\\\/tardive-dyskinesia-dawn-of-hope\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/curesz.org\\\/tardive-dyskinesia-dawn-of-hope\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/curesz.org\\\/tardive-dyskinesia-dawn-of-hope\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/curesz.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tardive Dyskinesia: Dawn of Hope\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/curesz.org\\\/#website\",\"url\":\"https:\\\/\\\/curesz.org\\\/\",\"name\":\"CURESZ Foundation\",\"description\":\"The CURESZ Foundation provides educational updates to patients, families, healthcare professionals and the general public about schizophrenia.\",\"publisher\":{\"@id\":\"https:\\\/\\\/curesz.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/curesz.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/curesz.org\\\/#organization\",\"name\":\"Curesz Foundation\",\"url\":\"https:\\\/\\\/curesz.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/curesz.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/curesz.org\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/cropped-Logo-with-Foundation-Custom.png\",\"contentUrl\":\"https:\\\/\\\/curesz.org\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/cropped-Logo-with-Foundation-Custom.png\",\"width\":200,\"height\":133,\"caption\":\"Curesz Foundation\"},\"image\":{\"@id\":\"https:\\\/\\\/curesz.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Cureszorg\\\/\",\"https:\\\/\\\/x.com\\\/cureszorg\",\"https:\\\/\\\/www.instagram.com\\\/cureszfoundation\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCT3uVzTt8jiJ2qdhuosHPvg\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tardive Dyskinesia: Dawn of Hope - CURESZ Foundation","description":"In 2017, the FDA brought new hope to those suffering with TD by approving two highly effective medications to treat it.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/curesz.org\/zh\/tardive-dyskinesia-dawn-of-hope\/","og_locale":"zh_CN","og_type":"article","og_title":"Tardive Dyskinesia: Dawn of Hope - CURESZ Foundation","og_description":"In 2017, the FDA brought new hope to those suffering with TD by approving two highly effective medications to treat it.","og_url":"https:\/\/curesz.org\/zh\/tardive-dyskinesia-dawn-of-hope\/","og_site_name":"CURESZ Foundation","article_publisher":"https:\/\/www.facebook.com\/Cureszorg\/","article_modified_time":"2023-11-15T19:21:44+00:00","twitter_card":"summary_large_image","twitter_site":"@cureszorg","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"4 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/curesz.org\/tardive-dyskinesia-dawn-of-hope\/","url":"https:\/\/curesz.org\/tardive-dyskinesia-dawn-of-hope\/","name":"Tardive Dyskinesia: Dawn of Hope - CURESZ Foundation","isPartOf":{"@id":"https:\/\/curesz.org\/#website"},"datePublished":"2021-07-19T23:52:51+00:00","dateModified":"2023-11-15T19:21:44+00:00","description":"In 2017, the FDA brought new hope to those suffering with TD by approving two highly effective medications to treat it.","breadcrumb":{"@id":"https:\/\/curesz.org\/tardive-dyskinesia-dawn-of-hope\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/curesz.org\/tardive-dyskinesia-dawn-of-hope\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/curesz.org\/tardive-dyskinesia-dawn-of-hope\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/curesz.org\/"},{"@type":"ListItem","position":2,"name":"Tardive Dyskinesia: Dawn of Hope"}]},{"@type":"WebSite","@id":"https:\/\/curesz.org\/#website","url":"https:\/\/curesz.org\/","name":"CURESZ\u57fa\u91d1\u4f1a","description":"CURESZ \u57fa\u91d1\u4f1a\u4e3a\u60a3\u8005\u3001\u5bb6\u5ead\u3001\u533b\u7597\u4fdd\u5065\u4e13\u4e1a\u4eba\u5458\u548c\u516c\u4f17\u63d0\u4f9b\u6709\u5173\u7cbe\u795e\u5206\u88c2\u75c7\u7684\u6559\u80b2\u66f4\u65b0\u3002","publisher":{"@id":"https:\/\/curesz.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/curesz.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/curesz.org\/#organization","name":"Curesz Foundation","url":"https:\/\/curesz.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/curesz.org\/#\/schema\/logo\/image\/","url":"https:\/\/curesz.org\/wp-content\/uploads\/2020\/02\/cropped-Logo-with-Foundation-Custom.png","contentUrl":"https:\/\/curesz.org\/wp-content\/uploads\/2020\/02\/cropped-Logo-with-Foundation-Custom.png","width":200,"height":133,"caption":"Curesz Foundation"},"image":{"@id":"https:\/\/curesz.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Cureszorg\/","https:\/\/x.com\/cureszorg","https:\/\/www.instagram.com\/cureszfoundation\/","https:\/\/www.youtube.com\/channel\/UCT3uVzTt8jiJ2qdhuosHPvg"]}]}},"_links":{"self":[{"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/pages\/4051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/comments?post=4051"}],"version-history":[{"count":5,"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/pages\/4051\/revisions"}],"predecessor-version":[{"id":5473,"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/pages\/4051\/revisions\/5473"}],"wp:attachment":[{"href":"https:\/\/curesz.org\/zh\/wp-json\/wp\/v2\/media?parent=4051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}